Insider trades

John T. Treace, CEO of Treace Medical Concepts TMCI, has filed 19 purchases and 1 sale on the open market. Over the past 12 months that comes to a net purchase of $1.2M. The latest trade was on 06/11.

John T. Treace

CEO
First filing
23/03/10
Trades
34 trades
Buys / sales
19 / 1
12-month net buying
$1.2M
Last trade
06/11

Trading activity

Transactions

Trade type
TMCI
Open-market buyAmendment06/10–06/1106/1224,606 sh2 trades$4.03avg.$99,113.94+0.3%
TMCI
Open-market buy06/10–06/1106/1152,317 sh2 trades$4.03avg.$210,772.08+0.7%
Open-market buy06/0106/0150,000 sh$3.56$178,000+0.7%
TMCI
Open-market buy05/26–05/2805/28115,520 sh3 trades$2.95avg.$340,362.06+1.6%
TMCI
Open-market buy05/12–05/1405/14153,763 sh3 trades$2.44avg.$375,666.98+2.2%
Open-market buy25/03/0425/03/0460,000 sh$8.73$523,800+0.9%
Open-market buy24/09/1624/09/1750,000 sh$5.31$265,500+0.8%
Open-market buy24/08/1424/08/1585,000 sh$6.00$510,000+1.3%
Open-market buy24/06/1124/06/1145,000 sh$5.88$264,600+0.7%
Open-market buy24/05/1724/05/20100,000 sh$5.56$556,000+1.6%
Open-market buy24/05/1424/05/14150,000 sh$5.12$768,000+2.5%
TMCI
Open-market buy24/05/10–24/05/1324/05/13300,000 sh2 trades$4.57avg.$1,371,000+5.2%
Open-market sale23/03/0923/03/102,075 sh$24.41$50,650.75−0.0%